Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders.

NCT03344328 · clinicaltrials.gov ↗

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy Induced Peripheral Neuropathy
Multiple Myeloma

Interventions

DRUG: Bortezomib

Sponsor

University Hospital, Clermont-Ferrand